hotspot -WSS

hotspot

author：entertainment 2025-09-30 00:46:07 - browse：52

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Bill would stop addiction treatment from triggering child abuse inquiry

WSS

How CRISPR works, explained in two minutes

Colorectal cancer study finds potential in overlooked immune cell

Was Amgen transparent enough on FDA's concern on cancer drug?

A Q&A with the global head of Boehringer Ingelheim's innovation unit

FDA authorizes Novavax’s updated Covid

Why Charlie Gard's case is so disturbing to Americans

hotspot

hotspot

explore

Apple is now the first public company to be valued at $3 trillion

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Tori Bowie and the unacceptable rates of Black maternal death

With heat waves through August, officials warn of health risks

In Memoriam: Notable people who died in 2023

Stroke deaths set to near 10 million globally by 2050

Guidelines to prevent youth baseball injuries need more muscle

Why Charlie Gard's case is so disturbing to Americans

Medicare details structure of new drug price negotiation program

Why Charlie Gard's case is so disturbing to Americans

hotspot

St. Louis police protesters begin picking up checks in $4.9 million settlement

Trump used to be more articulate. What could explain the change?

3 questions for the future of Biden's cancer moonshot

Phenylephrine and the overlooked value of the placebo effect

A Q&A with the global head of Boehringer Ingelheim's innovation unit

A virus, fished out of a lake, may have saved a man’s life

leisure time

entertainment

knowledge

entertainment